| NCT00432367 | London School of Hygiene and Tropical Medicine|Kwame Nkrumah University of Science and Technology | Malaria|Anaemia|Pregnancy | 2007-02 | PHASE3 |
| NCT01144702 | Oswaldo Cruz Foundation|Pan American Health Organization|Ministry of Health, Brazil|University of Sao Paulo | Falciparum Malaria | 2010-11 | PHASE2|PHASE3 |
| NCT03100045 | Johns Hopkins University|Frantz Viral Therapeutics, LLC|University of Wisconsin, Madison | HPV-Related Anal Intraepithelial Neoplasia|AIN2+3|Artesunate|Alternative Treatment|Anal Dysplasia|Precancerous Conditions|Human Papilloma Virus | 2017-04-20 | PHASE1 |
| NCT04713631 | Sanjay Gandhi Postgraduate Institute of Medical Sciences|St George´s, University of London | Crohn´s Disease | 2021-01-21 | PHASE2 |
| NCT00374205 | Bernhard Nocht Institute for Tropical Medicine|Presbyterian Health Service (PHS)|Kumasi Centre for Collaborative Research (KCCR)|School of Medical Sciences Kumasi (SMS+KNUST) | Malaria, Falciparum | 2006-09 | PHASE4 |
| NCT00538382 | NICHD Global Network for Women´s and Children´s Health|Global Network for Women´s and Children´s Health Research|Bill and Melinda Gates Foundation|Fogarty International Center of the National Institute of Health|National Center for Complementary and Integrative Health (NCCIH)|National Institute of Dental and Craniofacial Research (NIDCR)|National Cancer Institute (NCI)|RTI International|University of North Carolina|Kinshasa School of Public Health | Malaria | 2007-05 | PHASE1 |
| NCT01074905 | University of Oxford|Mahidol University | Vivax Malaria | 2010-05 | PHASE3 |
| NCT00509015 | Radboud University Medical Center|Kilimanjaro Christian Medical Centre, Tanzania|London School of Hygiene and Tropical Medicine | Malaria, Falciparum | 2008-02 | NA |
| NCT01659281 | Armed Forces Research Institute of Medical Sciences, Thailand | Plasmodium Falciparum Malaria | 2007-09 | NA |
| NCT00331708 | Professor Karen I Barnes|Global Fund|Medical Research Council, South Africa | Malaria | 2006-04 | NA |
| NCT06472258 | RESnTEC, Institute of Research | Malaria | 2023-03-01 | NA |
| NCT01350856 | University of Oxford|Mahidol University|Worldwide Antimalarial Resistance Network | Falciparum Malaria | 2011-05 | PHASE4 |
| NCT01378286 | Sanofi | Malaria | 2012-01 | PHASE3 |
| NCT00298610 | U.S. Army Medical Research and Development Command|Military Infectious Diseases Research Program (MIDRP) | Malaria | 2006-03 | PHASE2 |
| NCT03726593 | Armed Forces Research Institute of Medical Sciences, Thailand|National Center for Parasitology, Entomology, and Malaria Control (CNM)|Naval Medical Research Unit-2 (NAMRU-2) | Plasmodium Falciparum Malaria (Drug Resistant) | 2018-10-04 | PHASE4 |
| NCT00445796 | Sanofi | Malaria | 2005-06 | PHASE4 |
| NCT00694694 | London School of Hygiene and Tropical Medicine|National Institute for Medical Research, Tanzania | Malaria | 2008-06 | PHASE3 |
| NCT03764527 | Professor Anders Bj?rkman|Zanzibar Malaria Control Programme|World Health Organization | Plasmodium Falciparum Malaria | 2002-11-01 | PHASE4 |
| NCT01939886 | London School of Hygiene and Tropical Medicine|Kilimanjaro Christian Medical Centre, Tanzania|Radboud University Medical Center|European Union | Malaria | 2013-04 | PHASE3 |
| NCT00403260 | Medicines for Malaria Venture|Shin Poong Pharmaceuticals | Falciparum Malaria | 2007-01 | PHASE3 |
| NCT00203801 | University of Cape Town|World Health Organization|Medical Research Council, South Africa|Global Fund | Malaria | 2002-01 | NA |
| NCT00373607 | Institute of Tropical Medicine, Belgium | Malaria | 2003-07 | PHASE3 |
| NCT00203736 | University of Cape Town|World Health Organization|Medical Research Council, South Africa|Global Fund | Malaria | 2003-01 | NA |
| NCT00959517 | London School of Hygiene and Tropical Medicine|HealthNet TPO | Uncomplicated Falciparum Malaria | 2001-07 | PHASE2 |
| NCT00203814 | University of Cape Town|World Health Organization|Medical Research Council, South Africa | Malaria | 2004-01 | NA |
| NCT04921930 | Institut National de la Santé Et de la Recherche Médicale, France|Imagine Institute | Friedreich Ataxia | 2022-05-06 | PHASE1|PHASE2 |
| NCT05764746 | Muhimbili University of Health and Allied Sciences|The Swedish Research Council|Uppsala University | Uncomplicated Plasmodium Falciparum Malaria | 2023-05-01 | PHASE2|PHASE3 |
| NCT00356824 | National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections|Malaria | 2005-11 | |
| NCT00158548 | London School of Hygiene and Tropical Medicine|World Health Organization|HealthNet TPO|United Nations High Commissioner for Refugees|Malaria Control Program, Directorate of Malaria Control, Pakistan | Malaria|Falciparum Malaria|Vivax Malaria | 2001-06 | PHASE3 |
| NCT00111163 | Centers for Disease Control and Prevention|Kenya Medical Research Institute|Bill and Melinda Gates Foundation | Malaria|Anemia | 2004-03 | NA |
| NCT00486694 | London School of Hygiene and Tropical Medicine | Malaria, Vivax | 2004-03 | PHASE2 |
| NCT00639873 | Medical University of Vienna|International Centre for Diarrhoeal Disease Research, Bangladesh|World Health Organization | Malaria | 2008-06 | NA |
| NCT05273242 | Nepal Health Research Council|World Health Organization | COVID-19 | 2021-12-06 | PHASE4 |
| NCT03893097 | Institute of Tropical Medicine, Belgium|Institut de Recherche en Santé, de Surveillance épidémiologique et de Formation (IRESSEF) | Schistosoma Haematobium|Schistosoma Mansoni | 2019-10-14 | PHASE3 |
| NCT00287300 | University of North Carolina|Centers for Disease Control and Prevention | Malaria | 2003-09 | NA |
| NCT00316329 | Sanofi | Malaria | 2006-03 | PHASE3 |
| NCT01082731 | Centers for Disease Control and Prevention | Malaria | 2010-11 | PHASE4 |
| NCT00330902 | London School of Hygiene and Tropical Medicine|Tropical Medicine Research Institute|World Health Organization | Plasmodium Infections | 2004-01 | PHASE3 |
| NCT01165372 | Oxford University Clinical Research Unit, Vietnam|World Health Organization | Malaria | 2010-08 | PHASE2 |
| NCT02996695 | National Institute of Allergy and Infectious Diseases (NIAID) | Plasmodium Falciparum Infection | 2017-04-06 | PHASE1 |
| NCT02354534 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Frantz Viral Therapeutics, LLC | Cervical Intraepithelial Neoplasia Grade 2+3|High-risk HPV (Any Strain) | 2015-02 | PHASE1 |
| NCT00164359 | Centers for Disease Control and Prevention|Ministry of Health and Population, Malawi | Malaria, Falciparum | 2005-04 | PHASE4 |
| NCT00764036 | Heidelberg University|Hector-Stiftung|Dafra Pharma|Monika-Kutzner Stiftung, Berlin, Germany|HEIFAN-Heidelberger F?rderverein d. Ambulanz f. Naturheilkunde eV, Heidelberg, Germany | Metastatic Breast Cancer|Locally Advanced Breast Cancer | 2008-10 | PHASE1 |
| NCT02353026 | Georgetown University|United States Department of Defense | Solid Tumors | 2015-01 | PHASE1 |
| NCT06519994 | UNC Lineberger Comprehensive Cancer Center|National Cancer Institute (NCI)|Kenya Medical Research Institute|Maseno University School of Medicine, Kenya | Human Immunodeficiency Virus|Human Papillomavirus|Cervical Precancer | 2025-01-22 | PHASE2 |
| NCT06806956 | Tropical Diseases Research Centre, Zambia|Universiteit Antwerpen|University of Kinshasa|National Institute for Medical Research, Tanzania|Medicines for Malaria Venture|Université de Lubumbashi | Severe Malaria | 2024-03-10 | |
| NCT04675931 | Novartis Pharmaceuticals|Wellcome Trust|European and Developing Countries Clinical Trials Partnership (EDCTP) | Severe Malaria | 2022-03-07 | PHASE2 |
| NCT01319448 | London School of Hygiene and Tropical Medicine|Medical Research Council Unit, The Gambia|Wellcome Trust|University of Ilorin Teaching Hospital | Malaria|Sickle Cell Crisis | 2011-09 | PHASE1|PHASE2 |
| NCT00465257 | Karolinska University Hospital | Malaria | 2007-05 | PHASE4 |
| NCT00140361 | Centers for Disease Control and Prevention|United States Agency for International Development (USAID) | Malaria (Uncomplicated) | 2000-01 | PHASE4 |
| NCT02492178 | University of Oxford|Kinshasa School of Public Health | Malaria | 2015-07 | PHASE2 |
| NCT00146731 | London School of Hygiene and Tropical Medicine|National Institute for Medical Research, Tanzania | Malaria | 2004-01 | PHASE3 |
| NCT01976780 | Global Emerging Infections Surveillance and Response System|United States Army Medical Unit - Kenya|Walter Reed Army Institute of Research (WRAIR) | Malaria | 2013-06 | PHASE4 |
| NCT00936767 | University of Oxford|Mahidol University|Medicines for Malaria Venture | Uncomplicated Falciparum Malaria | 2010-10 | PHASE2|PHASE3 |
| NCT06075264 | Frantz Viral Therapeutics, LLC|The Cleveland Clinic | Vulvar Diseases|HPV Infection|Vulvar HSIL|Pre-Cancerous Dysplasia|HPV Disease|VIN, Usual Type|VIN 2 of Usual Type|VIN 3 of Usual Type|Vin II|Vin III|VIN Grade 2|VIN Grade 3|High Grade Intraepithelial Neoplasia | 2023-12-06 | PHASE2 |
| NCT01190371 | KEMRI-Wellcome Trust Collaborative Research Program|University of Oxford|Heidelberg University | Malaria | 2011-04 | PHASE4 |
| NCT00164710 | Centers for Disease Control and Prevention|Ministry of Health and Population, Malawi | Malaria, Falciparum | 2005-04 | PHASE4 |
| NCT00356005 | Medical University of Vienna|International Centre for Diarrhoeal Disease Research, Bangladesh|Armed Forces Research Institute of Medical Sciences, Thailand | Uncomplicated Falciparum Malaria | 2006-08 | PHASE2 |
| NCT06853184 | Amivas Inc. | CMV Infection | 2025-08-01 | PHASE2 |
| NCT00284687 | Hadassah Medical Organization|Institut für Klinische und Molekulare Virologie|University of Erlangen-Nürnberg Medical School | Cytomegalovirus Infections | 2006-07 | PHASE3 |
| NCT00378625 | Centro Internacional de Entrenamiento e Investigaciones Médicas|World Health Organization|Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS) | Malaria,Falciparum|Malaria|Antimalarials | 2000-04 | PHASE3 |
| NCT06165614 | UNC Lineberger Comprehensive Cancer Center|Gilead Sciences | Cervix Cancer|Cervix Neoplasm|Precancerous Conditions|Cervical Precancer | 2024-03-04 | PHASE1 |
| NCT01115439 | University of Oxford|National Malaria and Leishmaniasis Control Program, Afghanistan|World Health Organization | Falciparum Malaria | 2010-03 | |
| NCT00988507 | Sanofi | Plasmodium Falciparum Infection | 2009-10 | PHASE2 |
| NCT03214731 | Sun Yat-sen University|The First People´s Hospital of Yunnan|The First Affiliated Hospital of Nanchang University|General Hospital of Ningxia Medical University|First Affiliated Hospital of Fujian Medical University|Shenzhen Second People´s Hospital|The Third Xiangya Hospital of Central South University|Tongji Hospital | Lupus Nephritis | 2019-01-16 | PHASE4 |
| NCT02084602 | Instituto Nacional de Salud. Peru|U.S. Naval Medical Research Unit No.6 (NAMRU-6) | Malaria, Falciparum | 2014-06-18 | PHASE4 |
| NCT05750459 | National Institute of Allergy and Infectious Diseases (NIAID) | Plasmodium Falciparum Infection | 2023-11-29 | PHASE4 |
| NCT00132548 | London School of Hygiene and Tropical Medicine|Institut de Recherche pour le Developpement, Senegal|Cheikh Anta Diop University, Senegal|Ministry of Health, Senegal | Malaria | 2004-06 | PHASE3 |
| NCT00493363 | University of Oxford|World Health Organization|NCHADS - Ministry of Health of Cambodia|Mahidol University|Institut Pasteur|FHI 360|Li Ka Shing Foundation | Falciparum Malaria | 2007-06 | NA |
| NCT01122134 | Makerere University | Severe Malaria | 2010-05 | |
| NCT02092766 | University of Oxford|Kinshasa School of Public Health | Anaemia | 2014-06 | PHASE4 |
| NCT03814616 | Shin Poong Pharmaceutical Co. Ltd.|Medicines for Malaria Venture | Malaria,Falciparum | 2018-10-03 | PHASE2 |
| NCT05441410 | University Hospital Tuebingen|Sanaria Inc.|University of Oxford | Malaria | 2025-06-01 | PHASE1|PHASE2 |
| NCT00292942 | U.S. Army Medical Research and Development Command|Walter Reed Army Institute of Research (WRAIR) | Malaria|Malaria, Cerebral | 2006-06-12 | PHASE1 |
| NCT00132561 | London School of Hygiene and Tropical Medicine|Institut de Recherche pour le Developpement, Senegal|Institut de Recherche pour le Developpement|Cheikh Anta Diop University, Senegal|Ministry of Health, Senegal | Malaria | 2002-06 | PHASE2|PHASE3 |
| NCT02640495 | University of Oxford|Mahidol Oxford Tropical Medicine Research Unit|Oxford University Clinical Research Unit, Vietnam | Malaria | 2015-10 | |
| NCT01662700 | Mahidol University | Acute Uncomplicated Malaria With P.Vivax Infection | 2012-10 | PHASE4 |
| NCT07022743 | Obafemi Awolowo University | Chronic Myeloid Leukemia (CML) | 2025-07-01 | PHASE2 |
| NCT00550160 | Kwame Nkrumah University of Science and Technology|Department for International Development, United Kingdom|Malaria Consortium, UK|Center for International Health and Development | Malaria | 2007-04 | PHASE4 |
| NCT04387240 | Princess Nourah Bint Abdulrahman University | Covid 19 Positive|Corona Virus Infection | 2022-01 | PHASE2 |
| NCT01805232 | University of Khartoum|University of Kassala, Sudan|Kassala|Sudan | Malaria | 2013-03 | PHASE4 |
| NCT04098744 | Frantz Viral Therapeutics, LLC|Amarex Clinical Research|M.D. Anderson Cancer Center|Harris Health System (L.B.J. Hospital)|The Cleveland Clinic|University of Michigan|Florida Gynecologic Oncology | CIN 2+3|HPV Infection|Pre-Cancerous Dysplasia|Cervical Dysplasia|HPV Related Disease | 2020-09-09 | PHASE2 |
| NCT03792516 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Frantz Viral Therapeutics, LLC | Vulvar Dysplasia|HPV-Related Vulvar Intraepithelial Neoplasia|Preinvasive Vulvar Disease|Vulva Intraepithelial Neoplasia|Vulvar Diseases | 2019-04-17 | PHASE1 |
| NCT03431714 | National Institute for Medical Research, Tanzania|Muhimbili University of Health and Allied Sciences|World Health Organization | Uncomplicated Falciparum Malaria | 2017-07-14 | PHASE4 |
| NCT00722150 | Armed Forces Research Institute of Medical Sciences, Thailand|World Health Organization|Bill and Melinda Gates Foundation | Falciparum Malaria | 2008-07 | NA |
| NCT04330690 | Sunnybrook Health Sciences Centre|AbbVie|Apotex Inc.|World Health Organization|University of British Columbia|Arch Biopartners Inc. | COVID-19 | 2020-03-18 | PHASE3 |
| NCT07095309 | Metanoic Health Ltd.|Clinical Research Malaysia | Stage II+III Colon Cancer|Bowel Cancer | 2025-08-15 | PHASE2 |
| NCT00164216 | Centers for Disease Control and Prevention|National Institute of Health, Peru | Malaria Falciparum | 2005-03 | |
| NCT00479206 | Medical University of Vienna|Global Emerging Infections Surveillance and Response System|Armed Forces Research Institute of Medical Sciences, Thailand|National Center for Parasitology, Entomology and Malaria Control | Malaria, Falciparum | 2006-10 | NA |
| NCT00452907 | Sanofi | Malaria | 2005-07 | PHASE4 |
| NCT03768908 | Professor Anders Bj?rkman|Zanzibar Malaria Control Programme | Plasmodium Falciparum Malaria | 2005-01-05 | PHASE4 |
| NCT02304289 | University Hospital, Ghent|University Ghent|Anticancer Fund, Belgium | Hepatocellular Carcinoma | 2014-11 | PHASE1 |
| NCT01082718 | Centers for Disease Control and Prevention | Malaria|Pregnancy | 2010-03 | PHASE2|PHASE3 |
| NCT01955382 | National Institute of Allergy and Infectious Diseases (NIAID) | Malaria|Severe Malaria | 2013-09 | PHASE2 |
| NCT05555862 | Frantz Viral Therapeutics, LLC|Amarex CRO|University of California, San Francisco|Anal Dysplasia Clinic MidWest|Laser Surgery Care | Anal High Grade Squamous Intraepithelial Lesion|Anal Precancerous Condition|AIN 2+3|HPV Infection|Anal Dysplasia|HPV Disease | 2023-02-10 | PHASE2 |
| NCT00461578 | London School of Hygiene and Tropical Medicine|Institute of Tropical Medicine, Belgium | Malaria | 2005-04 | NA |
| NCT02604966 | National Institute of Malariology, Parasitology and Entomology, Vietnam|Institute of Tropical Medicine, Belgium | Drug Resistant Malaria Due to Plasmodium Falciparum | 2015-04 | PHASE4 |
| NCT04368910 | Medicines for Malaria Venture|Shin Poong Pharmaceuticals | Malaria | 2007-09-06 | PHASE3 |
| NCT01407887 | Heidelberg University | Uncomplicated Falciparum Malaria | 2011-08 | PHASE2 |
| NCT03201770 | Shin Poong Pharmaceutical Co. Ltd.|Medicines for Malaria Venture | Malaria,Falciparum | 2017-06-22 | PHASE4 |
| NCT00894374 | Pfizer | Falciparum Malaria | 2009-06 | PHASE1 |
| NCT00386503 | Sanofi | Malaria | 2006-06 | PHASE1 |
| NCT00459615 | U.S. Army Office of the Surgeon General|Military Infectious Diseases Research Program (MIDRP)|U.S. Army Medical Research and Development Command | Falciparum Malaria|Uncomplicated Malaria | 2007-04 | PHASE2 |
| NCT04706130 | University of Maryland, Baltimore|National Centre for Parasitology, Entomology and Malaria Control, Cambodia|Institut Pasteur du Cambodge | Vivax Malaria | 2021-04-15 | PHASE4 |
| NCT00118807 | London School of Hygiene and Tropical Medicine|Medical Research Council|National Malaria Control Programme, The Gambia | Malaria | 2003-08 | PHASE3 |
| NCT01107145 | Centers for Disease Control and Prevention | Plasmodium Vivax Malaria | 2011-02 | PHASE4 |
| NCT02663700 | National Institute of Allergy and Infectious Diseases (NIAID) | Plasmodium Falciparum Infection | 2016-04-07 | PHASE1 |
| NCT02653898 | Armed Forces Research Institute of Medical Sciences, Thailand|National Center for Parasitology, Entomology, and Malaria Control (CNM)|Ministry of National Defense, Royal Cambodian Armed Forces Department of Health | Malaria|Parasitic Diseases | 2016-01 | PHASE4 |
| NCT01374126 | Medical University of Vienna|International Centre for Diarrhoeal Disease Research, Bangladesh | Falciparum Malaria | 2011-07 | PHASE2 |
| NCT01707199 | University of Oxford|World Health Organization | Uncomplicated P. Falciparum Malaria | 2012-10 | NA |
| NCT02633098 | St George´s, University of London | Colorectal Cancer|Bowel Cancer | 2017-04-26 | PHASE2 |
| NCT00440999 | Medicines for Malaria Venture|Shin Poong Pharmaceuticals | Malaria | 2007-03 | PHASE3 |
| NCT06206564 | Frantz Viral Therapeutics, LLC|Laser Surgery Care, LLC|Anal Dysplasia Clinic MidWest | Anal High-grade Squamous Intraepithelial Lesion|Anal HSIL|Anal HPV Infection|AIN | 2024-01-12 | PHASE2 |
| NCT00164255 | Centers for Disease Control and Prevention|Ifakara Health Research and Development Centre | Malaria | 2003-01 | PHASE4 |
| NCT06872112 | Joseph C. Wu | Pulmonary Arterial Hypertension (PAH) | 2026-04-01 | PHASE1 |
| NCT00231452 | Hospital Clinic of Barcelona|European Commission | Malaria | 2005-09 | NA |
| NCT00299208 | National Institute of Allergy and Infectious Diseases (NIAID) | Plasmodium Falciparum Malaria | | PHASE2 |
| NCT00422084 | Medicines for Malaria Venture|Shin Poong Pharmaceuticals | Malaria | 2007-01 | PHASE3 |
| NCT00393679 | Institute of Tropical Medicine, Belgium|Liverpool School of Tropical Medicine|East African Network for Monitoring Antimalarial Treatment|Centre Muraz|University of Calabar|Tropical Diseases Research Centre, Zambia|University Hospital Tuebingen|Albert Schweitzer Hospital|Uganda Malaria Surveillance Project|Mbarara University of Science and Technology|Ministry of Health, Rwanda|University of Barcelona|Centro de Investigacao em Saude de Manhica | Fever|Malaria | 2007-07 | PHASE3 |
| NCT06555809 | Amivas Inc. | Malaria | 2024-10-06 | |
| NCT04374019 | Susanne Arnold | COVID|Sars-CoV2 | 2020-05-01 | PHASE2 |
| NCT06294912 | Merck Sharp & Dohme LLC | Malaria | 2024-04-18 | PHASE1 |
| NCT02974348 | University of Bamenda|Ministry of Science and Technology of the People?s Republic of China|National Institute for Parasitic Disease, Chinese Center for Disease Control and Prevention | Drug Resistant Malaria Due to Plasmodium Falciparum | 2013-01 | PHASE3 |
| NCT00541385 | Medicines for Malaria Venture|Shin Poong Pharmaceuticals | Malaria | 2007-10 | PHASE3 |
| NCT00292929 | U.S. Army Medical Research and Development Command | Malaria|Malaria, Cerebral | | PHASE1 |
| NCT07362498 | Strathmore University|Medicines for Malaria Venture|KEMRI-Wellcome Trust Collaborative Research Program|Kenya Ministry of Health|National Malaria Control Program|Homa Bay County Government, Kenya|Migori County Government, Kenya|Kenya Medical Supplies Authority (KEMSA), Kenya | Malaria Falciparum | 2020-06-01 | |
| NCT00289250 | London School of Hygiene and Tropical Medicine|Medical Research Council Unit, The Gambia | Asymptomatic P.Falciparum Malaria | 2001-05 | PHASE3 |
| NCT00354380 | Heidelberg University | Malaria | 2006-09 | PHASE2 |
| NCT06263582 | UNC Lineberger Comprehensive Cancer Center|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Cervix Cancer|Cervix Intraepithelial Neoplasia Grade 3|Cervix; Intraepithelial Neoplasia, Grade I|Cervix; Intraepithelial Neoplasia, Grade II | 2024-05-29 | PHASE1 |
| NCT03093129 | The 108 Military Central Hospital|Institute of Tropical Medicine, University of Tuebingen | Colorectal Cancer | 2018-01-08 | PHASE2 |
| NCT00612547 | National Malaria Control Programme, Madagascar|Population Services International|Reggio Terzo Mondo|Santé Net|Inter Aide Santé,|Adventist Development and Relief Agency|SAF FJKM|Sanofi|Institut Pasteur de Madagascar | Fever|Suspected Malaria | 2008-02 | |
| NCT00978172 | Mepha Ltd.|Centre Mère et Enfant de la Fondation Chantal Biya | Malaria | 2007-12 | PHASE4 |
| NCT00379821 | National Institute of Allergy and Infectious Diseases (NIAID) | Plasmodium Falciparum Infection | 2007-02 | PHASE3 |
| NCT00646126 | Tropical Medicine Research Institute|London School of Hygiene and Tropical Medicine|International Atomic Energy Agency | Plasmodium Falciparum|Asymptomatic Parataemia|Sub Patent Parasitaemia | 2005-08 | PHASE3 |
| NCT07095478 | Metanoic Health Ltd.|Clinical Research Malaysia | CIN 2+3 | 2025-08-01 | PHASE2 |
| NCT00875030 | Pfizer | Healthy Volunteers | 2009-06 | PHASE4 |
| NCT01152931 | University of Lagos, Nigeria | Malaria | 2010-08 | PHASE3 |
| NCT00682630 | Medicines for Malaria Venture|Shin Poong Pharmaceuticals | Malaria | 2007-09 | PHASE1 |